tirzepatide ελλαδα SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Cipla launches Yurpeak® (tirzepatide), a

The trend: Budget pressures, increased GLP-1 drug adoption, evolving government policies, and a growing preference for healthy eating are reshaping consumer grocery habitsforcing CPG giants like PepsiCo to rethink their strategy in order to remain competitive

Popular GLP-1 Options for Weight Loss Over the past several years, GLP-1 receptor agonists have moved from being niche diabetes treatments to some of the most widely discussed weight-loss medications in the world

With Trulicity, patients may be able to lose some weight

Getting the proper balance of macronutrients, namely protein, carbohydrates, fats, fibre as well as essential vitamins and minerals is key